Therapeutic Cooling Treatment Tested in HighProfile Sports Case

Studies of the impact of therapeutic cooling show reduced long-term brain damage and improved neurological function in sudden cardiac arrest patients. In the last few days, a professional football player and his doctors may have demonstrated similar neurological treatment benefits in association with spinal cord injury.

Cincinnati Sub-Zero (CSZ), a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, recently reviewed the results of successive years of cooling therapy studies around the world. "Improved outcomes in out-of-hospital cardiac arrest patients is clear in study after study of therapeutic hypothermia solutions -- and these are human trials that have taken place in the US, Canada, Norway, Sweden, and other countries," said Mark Beran, Vice President and General Manager of CSZ Medical.

"ILCOR (The International Liaison Committee on Resuscitation) produced the first international guidelines to include therapeutic cooling in 2000. The New England Journal of Medicine first noted hypothermia treatment benefits to cardiac patients in 2002. The American Heart Association published a therapy-supportive advisory statement in 2003, following an international standard-setting review. And, the international community issued additional recommendations in 2005. More and more emergency services providers are adopting the treatment, and it is increasingly clear that the solution timing -- the sooner, the better -- is vital," said Beran.

Where therapeutic cooling has been shown to halt brain cell death, it now may very well be illustrating it also can hinder spinal nerve death. In the case of the football player's neurological damage, doctors and experts speculate the hypothermia may have contributed to slowing his body's ability to produce swelling and irritation, reducing the possibility of spinal nerve death.

While controversy still exists regarding the exact means of neurological improvement, studies do show that patients receiving controlled cooling therapy are more likely to survive their hospital stay, and be discharged with more neurological function.

The 1st Annual International Therapeutic Temperature Management (TTM Congress) will be held in Cancun, Mexico from December 4-7, 2007. The TTM Congress will convene experts from around the world to review practices and research in therapeutic hypothermia and patient temperature modulation. CSZ Medical is an unrestricted educational grant sponsor for the event. More information is available at TTMCongress.com (


Therapeutic Cooling Treatment Tested in HighProfile Sports Case



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***